title: Neuroprotection in glaucoma: is there a future role of Helicobacter pylori eradication?
authors.forename: Jannis
authors.initials: J
authors.lastname: Kountouras
authors.forename: Christos
authors.initials: C
authors.lastname: Zavos
authors.forename: Georgia
authors.initials: G
authors.lastname: Deretzi
authors.forename: Stergios A
authors.initials: SA
authors.lastname: Polyzos
authors.forename: Emmanuel
authors.initials: E
authors.lastname: Gavalas
authors.forename: Elena
authors.initials: E
authors.lastname: Tsiaousi
authors.forename: Evaggelia
authors.initials: E
authors.lastname: Giartza-Taxidou
authors.forename: Dimitrios
authors.initials: D
authors.lastname: Chatzopoulos
authors.forename: Stavros
authors.initials: S
authors.lastname: Michael
authors.forename: George
authors.initials: G
authors.lastname: Tsarouchas
mesh_terms: D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D017209:Apoptosis; D002470:Cell Survival; D005901:Glaucoma / Q000382:microbiology / Q000517:prevention & control*; D016481:Helicobacter Infections / Q000188:drug therapy*; D016480:Helicobacter pylori; D006801:Humans; D009901:Optic Nerve Diseases / Q000382:microbiology / Q000517:prevention & control*; D012165:Retinal Ganglion Cells / Q000187:drug effects / Q000382:microbiology
chemical_list: D000900:Anti-Bacterial Agents